Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 58.65
+2.95 (5.30%)
Sep 30, 2026, 4:08 PM HKT
Shanghai Henlius Biotech Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Shanghai Henlius Biotech stock has a consensus rating of "Strong Buy" and an average price target of $102.15. The average 1-year stock price forecast is 74.17% higher than the current stock price, while the lowest is $91.84 (+56.59%) and the highest is $120.19 (+104.93%).
Price Target: $102.15 (+74.17%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Shanghai Henlius Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 7 | 7 | 6 | 7 | 7 |
| Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst CICC No rating | CICC | Buy Maintains $102.91 | Buy | Maintains | $102.91 | +75.46% | Sep 1, 2026 |
Unknown Analyst SPDB No rating | SPDB | Buy Maintains $95.10 | Buy | Maintains | $95.10 | +62.15% | Aug 26, 2026 |
Unknown Analyst SDIC Securities No rating | SDIC Securities | Buy Maintains $90.22 | Buy | Maintains | $90.22 | +53.83% | Aug 26, 2026 |
| CMB International Securities | CMB International Securities | Buy Maintains $101.66 | Buy | Maintains | $101.66 | +73.33% | Aug 25, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $95.20 | Buy | Maintains | $95.20 | +62.32% | Aug 25, 2026 |
Financial Forecast
Revenue This Year
7.59B
from 6.67B
Increased by 13.85%
Revenue Next Year
7.57B
from 7.59B
Decreased by -0.23%
EPS This Year
1.69
from 1.51
Increased by 11.75%
EPS Next Year
1.53
from 1.69
Decreased by -9.17%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.